Company Announcements

In September, Abcam announced that CFO Jeff Iliffe will resign within 12 months. Mara Glickman Aspinall has replaced him on the Board. She was formerly president and CEO of Ventana Medical Systems.

Desktop Genetics, maker of the DESKGEN genome editing software, raised £1.37 million ($2.15 million).

ArcherDX announced a partnership with BioChain to screen BioChain’s tumor FFPE samples that will be released under the CancerSeq Plus brand.

Comprehensive Biomarker Center was named an Agilent Technologies Certified Service Provider for miRNA profiling.

Product Introductions

In August, Allele Biotechnology & Pharmaceuticals released Nano-Antibodies, also known as single domain antibodies, camelid antibodies and VHH antibodies, that were isolated from llamas against bFGF, P16, VEGF and TNFa.

In September, Thermo Fisher Scientific introduced the Gibco ExpiCHO Expression System, a fully redesigned transient expression system, which can achieve protein yields of up to 3 g/L.

Thermo Fisher Scientific released the GIBCO CTS Immune Cell SR for immune cell culture. It can replace human serum and fetal bovine serum. It is T cell–qualified and classified as an FDA Class 1 IVD medical device.

MedCityNews.com reported that Illumina is soliciting partners for its “PopArray” consortium to collect three million genomic samples in order to develop a 750,000 SNP multiethnic microarray for genotyping.

Vitro Biopharma introduced a new line of stem cell–derived neuronal and renal cells, extending their stem cell–derived cells to include cardiac, neural and renal cells.

Affymetrix launched an automation friendly, 384-well format of its QuantiGene Singleplex Assay.

Bioo Scientific introduced the MaxDiscovery Homocysteine Enzymatic Assay Kit.

Diagenode launched what it called the first polyclonal antibody targeting CRISPR/Cas9 validated for chromatin immunoprecipitation.

In October, DeNovix introduced three new dsDNA fluorescence quantification assays.

Affymetrix launched the Axiom Transplant Genotyping Array, comprising around 780,000 markers, for improving transplantation success and individualizing donor/patient selection and treatment, and for research.

Sales/Orders of Note

Affymetrix announced in September its selection as the genotyping supplier by China’s Green Super Rice project, which is part of an effort to develop at least 15 new rice varieties for small-hold farmers.